Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.280
-0.090 (-6.57%)
Jun 15, 2026, 4:00 PM EDT - Market closed
Pulmonx Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -53.21 | -54 | -56.39 | -60.84 | -58.92 | -48.66 |
Depreciation & Amortization | 1 | 1.05 | 1.49 | 1.55 | 1.51 | 0.87 |
Stock-Based Compensation | 19.76 | 21.23 | 22.96 | 22.1 | 16.45 | 10.53 |
Other Adjustments | 1.93 | 1.27 | 2.11 | 2.14 | 2.9 | 3.72 |
Change in Receivables | 3 | 1.08 | -1.31 | -3.1 | -2.19 | -2.43 |
Changes in Inventories | -2.13 | -0.77 | -0.23 | 0.92 | -3.64 | -6.46 |
Changes in Accounts Payable | -0.67 | 0.27 | 2.28 | -0.35 | 0.25 | 0.09 |
Changes in Accrued Expenses | 1.45 | -2.28 | 0.46 | 3.18 | 0.15 | 4.8 |
Changes in Income Taxes Payable | 0.22 | 0.19 | -0.04 | 0.07 | -0.12 | 0.02 |
Changes in Unearned Revenue | -0.1 | -0.12 | 0.03 | -0.02 | -0.04 | 0.09 |
Changes in Other Operating Activities | -0.48 | -0.3 | -2.9 | -3.25 | -1.42 | -3.96 |
Operating Cash Flow | -29.25 | -32.38 | -31.54 | -37.61 | -45.08 | -41.39 |
Capital Expenditures | -0.16 | -0.45 | -1.45 | -0.81 | -1.32 | -3.67 |
Purchases of Intangible Assets | -0.16 | -0.45 | -1.45 | -0.81 | -1.32 | -3.67 |
Purchases of Investments | -1.73 | -5.65 | -27.91 | -46.2 | -47.19 | -52.58 |
Proceeds from Sale of Investments | 16.05 | 36.59 | 46.84 | 45 | 44.28 | 10 |
Investing Cash Flow | 14.16 | 30.48 | 17.48 | -2.01 | -4.23 | -46.26 |
Long-Term Debt Issued | 38.79 | - | - | 20 | - | - |
Long-Term Debt Repaid | -37.08 | -0.1 | -0.1 | -0.09 | -0.09 | - |
Net Long-Term Debt Issued (Repaid) | 1.71 | -0.1 | -0.1 | 19.91 | -0.09 | - |
Issuance of Common Stock | 0.58 | 1 | 1.46 | 1.49 | 2.59 | 4.52 |
Repurchase of Common Stock | - | - | - | - | -0.03 | -0.03 |
Net Common Stock Issued (Repurchased) | 0.58 | 1 | 1.46 | 1.49 | 2.56 | 4.5 |
Other Financing Activities | -0.05 | -0.07 | - | - | -0.05 | -0.04 |
Financing Cash Flow | 2.2 | 0.83 | 1.36 | 21.4 | 2.42 | 4.46 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -0.09 | -0.09 | 0.08 | 0.03 | 0.15 | 0.11 |
Net Cash Flow | -12.98 | -1.15 | -12.62 | -18.18 | -46.74 | -83.08 |
Free Cash Flow | -29.41 | -32.83 | -32.98 | -38.42 | -46.4 | -45.06 |
FCF Margin | -33.22% | -36.28% | -39.37% | -55.94% | -86.47% | -93.07% |
Free Cash Flow Per Share | -0.71 | -0.81 | -0.84 | -1.01 | -1.25 | -1.25 |
Levered Free Cash Flow | -52.37 | -56.5 | -56.84 | -39.65 | -63.64 | -56.88 |
Unlevered Free Cash Flow | -53.56 | -56.69 | -58.57 | -61.23 | -63.62 | -55.86 |